Medical device companies seeking reliable contract manufacturing partners now have access to expanded production capacity at A&M BioMedical's Laguna Hills, California facility. The ISO 13485-certified manufacturer announced today that it has increased its manufacturing capabilities to better serve clients requiring production runs from 150 to 150,000+ units per month. This expansion is poised to help original equipment manufacturers reduce capital expenditures and focus on core competencies amid a growing contract manufacturing market.
A&M BioMedical, with over 30 years of experience, provides turnkey services including medical device assembly, packaging, labeling, sterilization coordination, and supply chain management. The facility is FDA-registered and features HEPA-filtered cleanrooms for both sterile and non-sterile devices. The company reports a 98% first-pass yield rate and zero FDA 483 findings in recent inspections, underscoring its commitment to quality and regulatory compliance.
The expansion comes as the global medical device contract manufacturing market is projected to grow significantly over the next decade, driven by demand for specialized production capabilities and regulatory expertise. By increasing its capacity, A&M BioMedical is positioning itself to meet this rising demand while maintaining high standards.
"Our expanded capacity reflects our commitment to supporting medical device companies with reliable and compliant manufacturing solutions," said [Name], [Title] at A&M BioMedical. "With over three decades of experience, we have developed processes that prioritize quality and efficiency for our clients."
A&M BioMedical's services span the full production lifecycle, from process development and validation to full-scale production. Its cleanrooms are designed to meet strict regulatory requirements, and its quality management system is certified to ISO 13485, the international standard for medical device quality management. The company's ability to handle varied production volumes accommodates both small-batch and high-volume manufacturing needs, offering flexibility to clients.
As a contract medical device manufacturer, A&M BioMedical continues to play a vital role in the medical device supply chain. The expansion of its Laguna Hills facility is expected to enhance its ability to serve existing clients and attract new ones, contributing to the overall efficiency of medical device production.
Industry analysts note that contract manufacturing allows medical device companies to leverage specialized expertise and infrastructure without the burden of maintaining their own facilities. A&M BioMedical's expanded capacity is likely to be welcomed by clients looking to scale production quickly and cost-effectively.
The company's track record of quality is evidenced by its 98% first-pass yield rate and zero FDA 483 findings, which indicate strong compliance with regulatory standards. This track record, combined with expanded capacity, positions A&M BioMedical as a reliable partner for medical device companies.
Looking ahead, A&M BioMedical aims to continue investing in its capabilities to meet evolving client needs. The company's commitment to quality and efficiency, backed by over three decades of experience, ensures that it remains a trusted name in contract manufacturing.
For more information about A&M BioMedical and its services, visit their website. The company is based in Laguna Hills, California, and serves clients worldwide.
Media Contact
Contact person: Melissa Fontes, CFO
Company: A&M Biomedical, Inc.
Phone: +1 (949) 916-4778
Website: https://ambiomedical.com/
